Literature DB >> 17568788

Opposed independent effects and epistasis in the complex association of IRF5 to SLE.

I Ferreiro-Neira1, M Calaza, E Alonso-Perez, M Marchini, R Scorza, G D Sebastiani, F J Blanco, I Rego, R Pullmann, R Pullmann, C G Kallenberg, M Bijl, F N Skopouli, M Mavromati, S Migliaresi, N Barizzone, S Ruzickova, C Dostal, R E Schmidt, T Witte, C Papasteriades, I Kappou-Rigatou, E Endreffy, A Kovacs, J Ordi-Ros, E Balada, P Carreira, J J Gomez-Reino, A Gonzalez.   

Abstract

Genetic variation in the interferon regulatory factor 5 (IRF5) gene affects systemic lupus erythematosus (SLE) susceptibility. However, association is complex and incompletely defined. We obtained fourteen European sample collections with a total of 1383 SLE patients and 1614 controls to better define the role of the different IRF5 variants. Eleven polymorphisms were studied, including nine tag single nucleotide polymorphisms (SNPs) and two extra functional polymorphisms. Two tag SNPs showed independent and opposed associations: susceptibility (rs10488631, P<10(-17)) and protection (rs729302, P<10(-6)). Haplotype analyses showed that the susceptibility haplotype, identified by the minor allele of rs10488631, can be due to epistasis between three IRF5 functional polymorphisms. These polymorphisms determine increased mRNA expression, a splice variant with a different exon 1 and a longer proline-rich region in exon 6. This result is striking as none of the three polymorphisms had an independent effect on their own. Protection was independent of these polymorphisms and seemed to reside in the 5' side of the gene. In conclusion, our results help to understand the role of the IRF5 locus in SLE susceptibility by clearly separating protection from susceptibility as caused by independent polymorphisms. In addition, we have found evidence for epistasis between known functional polymorphisms for the susceptibility effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568788     DOI: 10.1038/sj.gene.6364407

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  22 in total

Review 1.  Targeting Toll-like receptors: emerging therapeutics?

Authors:  Elizabeth J Hennessy; Andrew E Parker; Luke A J O'Neill
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

2.  Phenotype and function of B cells and dendritic cells from interferon regulatory factor 5-deficient mice with and without a mutation in DOCK2.

Authors:  Kei Yasuda; Kerstin Nündel; Amanda A Watkins; Tania Dhawan; Ramon G Bonegio; Jessalyn M Ubellacker; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  Int Immunol       Date:  2013-01-04       Impact factor: 4.823

3.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

4.  Association between the rs2004640 functional polymorphism of interferon regulatory factor 5 and systemic lupus erythematosus: a meta-analysis.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2008-11-29       Impact factor: 2.631

5.  Association of IRF5 polymorphisms with activation of the interferon alpha pathway.

Authors:  Ornella J Rullo; Jennifer M P Woo; Hui Wu; Alice D C Hoftman; Paul Maranian; Brittany A Brahn; Deborah McCurdy; Rita M Cantor; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2009-10-23       Impact factor: 19.103

Review 6.  The genetics and epigenetics of autoimmune diseases.

Authors:  Anura Hewagama; Bruce Richardson
Journal:  J Autoimmun       Date:  2009-04-05       Impact factor: 7.094

7.  Association of rs10954213 polymorphisms and haplotype diversity in interferon regulatory factor 5 with systemic lupus erythematosus: a meta-analysis.

Authors:  Hui-Feng Liu; Xiang-Jie An; Yan Yang; Liu Yang; Yan Li; Chang-Zheng Huang; Juan Tao; Ya-Ting Tu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

8.  Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study.

Authors:  Marian Suarez-Gestal; Manuel Calaza; Emöke Endreffy; Rudolf Pullmann; Josep Ordi-Ros; Gian Domenico Sebastiani; Sarka Ruzickova; Maria Jose Santos; Chryssa Papasteriades; Maurizio Marchini; Fotini N Skopouli; Ana Suarez; Francisco J Blanco; Sandra D'Alfonso; Marc Bijl; Patricia Carreira; Torsten Witte; Sergio Migliaresi; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

9.  The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.

Authors:  Leah C Kottyan; Erin E Zoller; Jessica Bene; Xiaoming Lu; Jennifer A Kelly; Andrew M Rupert; Christopher J Lessard; Samuel E Vaughn; Miranda Marion; Matthew T Weirauch; Bahram Namjou; Adam Adler; Astrid Rasmussen; Stuart Glenn; Courtney G Montgomery; Gideon M Hirschfield; Gang Xie; Catalina Coltescu; Chris Amos; He Li; John A Ice; Swapan K Nath; Xavier Mariette; Simon Bowman; Maureen Rischmueller; Sue Lester; Johan G Brun; Lasse G Gøransson; Erna Harboe; Roald Omdal; Deborah S Cunninghame-Graham; Tim Vyse; Corinne Miceli-Richard; Michael T Brennan; James A Lessard; Marie Wahren-Herlenius; Marika Kvarnström; Gabor G Illei; Torsten Witte; Roland Jonsson; Per Eriksson; Gunnel Nordmark; Wan-Fai Ng; Juan-Manuel Anaya; Nelson L Rhodus; Barbara M Segal; Joan T Merrill; Judith A James; Joel M Guthridge; R Hal Scofield; Marta Alarcon-Riquelme; Sang-Cheol Bae; Susan A Boackle; Lindsey A Criswell; Gary Gilkeson; Diane L Kamen; Chaim O Jacob; Robert Kimberly; Elizabeth Brown; Jeffrey Edberg; Graciela S Alarcón; John D Reveille; Luis M Vilá; Michelle Petri; Rosalind Ramsey-Goldman; Barry I Freedman; Timothy Niewold; Anne M Stevens; Betty P Tsao; Jun Ying; Maureen D Mayes; Olga Y Gorlova; Ward Wakeland; Timothy Radstake; Ezequiel Martin; Javier Martin; Katherine Siminovitch; Kathy L Moser Sivils; Patrick M Gaffney; Carl D Langefeld; John B Harley; Kenneth M Kaufman
Journal:  Hum Mol Genet       Date:  2014-09-08       Impact factor: 6.150

10.  Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study.

Authors:  Elisa Alonso-Perez; Marian Suarez-Gestal; Manuel Calaza; Josep Ordi-Ros; Eva Balada; Marc Bijl; Chryssa Papasteriades; Patricia Carreira; Fotini N Skopouli; Torsten Witte; Emöke Endreffy; Maurizio Marchini; Sergio Migliaresi; Gian Domenico Sebastiani; Maria Jose Santos; Ana Suarez; Francisco J Blanco; Nadia Barizzone; Rudolf Pullmann; Sarka Ruzickova; Bernard R Lauwerys; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.